PSMA5 and prostate carcinoma: Previously, aberrantly high expression of PSMA5 has been detected in prostate cancer,24 lung adenocarcinoma (LUAD),25 pulmonary neuroendocrine tumors,26 and endometrial cancer,27 hinting its associations with progression of above cancers.25